Hypermethylation of some tumor suppress gene promoters (TSG) that affect the prognosis can partially explain the poor prognosis associated with patients with DNMT overexpression [47], [48], [49], [50], although methylation of most gene promoters doesn’t have high correlation with the expression of DNMTs [35], [51]. This evidence concerns the gene DNMT1 and neoplasm.